日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Influence of the combination of SGLT2 inhibitors and GLP-1 receptor agonists on eGFR decline in type 2 diabetes: post-hoc analysis of RECAP study

SGLT2抑制剂和GLP-1受体激动剂联合用药对2型糖尿病患者eGFR下降的影响：RECAP研究的事后分析

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2024.1358573
Muta, Yoshimi; Kobayashi, Kazuo; Toyoda, Masao; Tone, Atsuhito; Suzuki, Daisuke; Tsuriya, Daisuke; Machimura, Hideo; Shimura, Hidetoshi; Takeda, Hiroshi; Yokomizo, Hisashi; Takeshita, Kei; Chin, Keiichi; Kanasaki, Keizo; Tamura, Kouichi; Miyauchi, Masaaki; Saburi, Masuo; Morita, Miwa; Yomota, Miwako; Kimura, Moritsugu; Hatori, Nobuo; Nakajima, Shinichi; Ito, Shun; Tsukamoto, Shunichiro; Murata, Takashi; Matsushita, Takaya; Furuki, Takayuki; Hashimoto, Takuya; Umezono, Tomoya; Takashi, Yuichi; Kawanami, Daiji
SGLT2
GLP-1
信号转导
代谢
糖尿病
发表日期：2024
文献求助 收藏

Renoprotective effects of combination treatment with sodium-glucose cotransporter inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus according to preceding medication

根据既往用药情况，评估钠-葡萄糖协同转运蛋白抑制剂和GLP-1受体激动剂联合治疗对2型糖尿病患者的肾脏保护作用

期刊:
影响因子:
doi:10.1177/14791641231222837
Kobayashi, Kazuo; Toyoda, Masao; Tone, Atsuhito; Kawanami, Daiji; Suzuki, Daisuke; Tsuriya, Daisuke; Machimura, Hideo; Shimura, Hidetoshi; Takeda, Hiroshi; Yokomizo, Hisashi; Takeshita, Kei; Chin, Keiichi; Kanasaki, Keizo; Miyauchi, Masaaki; Saburi, Masuo; Morita, Miwa; Yomota, Miwako; Kimura, Moritsugu; Hatori, Nobuo; Nakajima, Shinichi; Ito, Shun; Tsukamoto, Shunichiro; Murata, Takashi; Matsushita, Takaya; Furuki, Takayuki; Hashimoto, Takuya; Umezono, Tomoya; Muta, Yoshimi; Takashi, Yuichi; Tamura, Kouichi
糖尿病
信号转导
GLP-1
代谢
发表日期：2023
文献求助 收藏

Multinational Observational Study to Understand Insulin Treatment Intensification: Japanese Subgroup Analysis of the MOSAIc Study

一项旨在了解胰岛素治疗强化的多国观察性研究：MOSAIc 研究的日本亚组分析

期刊:Diabetes Therapy
影响因子:2.6
doi:10.1007/s13300-021-01195-8
Matsuba, Ikuro; Kawata, Takehiro; Ajima, Miho; Umezawa, Shinichi; Kaneshiro, Mizuki; Asakura, Taro; Machimura, Hideo; Sawa, Tasuku; Tanaka, Keiji; Takeda, Hiroshi; Imaoka, Takeshi; Kanamori, Akira
免疫/内分泌
发表日期：2022
文献求助 收藏

Blood pressure after treatment with sodium-glucose cotransporter 2 inhibitors influences renal composite outcome: Analysis using propensity score-matched models

钠-葡萄糖协同转运蛋白2抑制剂治疗后血压影响肾脏复合结局：基于倾向评分匹配模型的分析

期刊:Journal of Diabetes Investigation
影响因子:3
doi:10.1111/jdi.13318
Kobayashi, Kazuo; Toyoda, Masao; Hatori, Nobuo; Furuki, Takayuki; Sakai, Hiroyuki; Umezono, Tomoya; Ito, Shun; Suzuki, Daisuke; Takeda, Hiroshi; Minagawa, Fuyuki; Degawa, Hisakazu; Yamamoto, Hareaki; Machimura, Hideo; Chin, Keiichi; Hishiki, Toshimasa; Takihata, Masahiro; Aoyama, Kouta; Umezawa, Shinichi; Minamisawa, Kohsuke; Aoyama, Togo; Hamada, Yoshiro; Suzuki, Yoshiro; Hayashi, Masahiro; Hatori, Yutaka; Sato, Kazuyoshi; Miyakawa, Masaaki; Tamura, Kouichi; Kanamori, Akira
发表日期：2021
文献求助 收藏

Effects of ipragliflozin on the development and progression of kidney disease in patients with type 2 diabetes: An analysis from a multicenter prospective intervention study

伊格列净对2型糖尿病患者肾脏疾病发生和进展的影响：一项多中心前瞻性干预研究的分析

期刊:Journal of Diabetes Investigation
影响因子:3
doi:10.1111/jdi.13248
Matsuba, Ikuro; Kawata, Takehiro; Iemitsu, Kotaro; Asakura, Taro; Amemiya, Hikaru; Ishikawa, Masashi; Ito, Syogo; Kaneshiro, Mizuki; Kanamori, Akira; Kubota, Akira; Shinoda, Kazuaki; Takai, Masahiko; Takuma, Tetsuo; Takihata, Masahiro; Takeda, Hiroshi; Tanaka, Keiji; Matsuzawa, Yoko; Machimura, Hideo; Minagawa, Fuyuki; Minami, Nobuaki; Mokubo, Atsuko; Miyakawa, Masaaki; Terauchi, Yasuo; Tanaka, Yasushi
糖尿病
代谢
发表日期：2020
文献求助 收藏

Relation between Blood Pressure Management and Renal Effects of Sodium-Glucose Cotransporter 2 Inhibitors in Diabetic Patients with Chronic Kidney Disease

血压管理与钠-葡萄糖协同转运蛋白2抑制剂对合并慢性肾病糖尿病患者肾脏影响的关系

期刊:Journal of Diabetes Research
影响因子:3.4
doi:10.1155/2019/9415313
Kobayashi, Kazuo; Toyoda, Masao; Kaneyama, Noriko; Hatori, Nobuo; Furuki, Takayuki; Sakai, Hiroyuki; Takihata, Masahiro; Umezono, Tomoya; Ito, Shun; Suzuki, Daisuke; Takeda, Hiroshi; Kanamori, Akira; Degawa, Hisakazu; Yamamoto, Hareaki; Machimura, Hideo; Mokubo, Atsuko; Chin, Keiichi; Obana, Mitsuo; Hishiki, Toshimasa; Aoyama, Kouta; Nakajima, Shinichi; Umezawa, Shinichi; Shimura, Hidetoshi; Aoyama, Togo; Miyakawa, Masaaki
糖尿病
代谢
发表日期：2019
文献求助 收藏

Estimating carbon fixation of plant organs for afforestation monitoring using a process-based ecosystem model and ecophysiological parameter optimization

利用基于过程的生态系统模型和生态生理参数优化方法估算植物器官的碳固定量，以用于造林监测。

期刊:Ecology and Evolution
影响因子:2.3
doi:10.1002/ece3.5328
Miyauchi, Tatsuya; Machimura, Takashi; Saito, Makoto
发表日期：2019
文献求助 收藏

Efficacy and Safety of Alogliptin in Elderly Patients With Type 2 Diabetes Mellitus

阿格列汀治疗老年2型糖尿病患者的疗效和安全性

期刊:Journal of Clinical Medicine Research-Canada
影响因子:2
doi:10.14740/jocmr3953
Takeda, Hiroshi; Sasai, Nobuo; Ito, Shogo; Obana, Mitsuo; Takuma, Tetsuo; Takai, Masahiko; Kaneshige, Hideaki; Machimura, Hideo; Kanamori, Akira; Matsuba, Ikuro
糖尿病
代谢
发表日期：2019
文献求助 收藏

Cross-National Variation in Glycemic Control and Diabetes-Related Distress Among East Asian Patients Using Insulin: Results from the MOSAIc Study

东亚胰岛素治疗患者血糖控制及糖尿病相关困扰的跨国差异：MOSAIc 研究结果

期刊:Diabetes Therapy
影响因子:2.6
doi:10.1007/s13300-016-0178-7
Matsuba, Ikuro; Sawa, Tasuku; Kawata, Takehiro; Kanamori, Akira; Jiang, Dingfeng; Machimura, Hideo; Takeda, Hiroshi; Han, Jeong Hee; Wang, Ke; Tanaka, Keiji; Shen, Li; Ajima, Miho; Kaneshiro, Mizuki; Kim, Sang-Wook; Umezawa, Shinichi; Asakura, Taro; Suzuki, Shuichi; Kim, Seoyoung C
代谢
糖尿病
免疫/内分泌
发表日期：2016
文献求助 收藏

Efficacy and Safety of Alogliptin in Patients With Type 2 Diabetes: Analysis of the ATTAK-J Study

阿格列汀治疗2型糖尿病患者的疗效和安全性：ATTAK-J研究分析

期刊:Journal of Clinical Medicine Research-Canada
影响因子:2
doi:10.14740/jocmr2418w
Takeda, Hiroshi; Sasai, Nobuo; Ito, Shogo; Obana, Mitsuo; Takuma, Tetsuo; Takai, Masahiko; Kaneshige, Hideaki; Machimura, Hideo; Kanamori, Akira; Nakajima, Kazumi; Matsuba, Ikuro
代谢
糖尿病
发表日期：2016
文献求助 收藏